The effect of neuromuscular blocking agents on the management of mechaninal ventilation with supraglottic airway device and the influence of the differences between anesthetic agents or supraglottic airway devices

The effect of neuromuscular blocking agents on the management of mechaninal ventilation with supraglottic airway device and the influence of the differences between anesthetic agents or supraglottic airway devices - The effect of NMBAs on the management of mechaninal ventilation with SGA devices

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027061

Enrollment

Registered

2017-04-20

Start date

2017-04-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients scheduled for elective surgery under general anesthesia

Interventions

rocuronium dose types of anesthetic drugs types of supraglottic airway devices

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients scheduled for elective surgery under general anesthesia

Exclusion criteria

Exclusion criteria: morbidly obese(BMI>=35 kg/m2) gastroeshophageal reflux

Design outcomes

Primary

Measure	Time frame
Compare the decreased leakage volume after rocuronium administration between different dose of rocuronium administrated groups	—

Countries

Japan

Contacts

Public ContactMasafumi Fujimoto

Nishinihon Hospital department of anesthesiology

mfujimoto-kmm@umin.ac.jp096-380-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026